Evidence mapPaperPMID 41906174Full record

ArticleCardiovascular diabetology2026

Associations of cumulative exposure and dynamic trajectories of the triglyceride-total cholesterol-body weight index with new-onset cardiometabolic multimorbidity in middle-aged and older Chinese adults: evidence from a nationwide prospective cohort study.

Xiao Chen, Chaochao Wang, Qi Huang, Yuan Luo, Zhe Wu, Jing Chen, Haibo Gong

Erratum issuedAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Xiao Chen *Department of Orthopedics, the First People's Hospital of Neijiang, Neijiang, 641000, Sichuan Province, China.
Chaochao Wang *Department of Orthopedics, the First People's Hospital of Neijiang, Neijiang, 641000, Sichuan Province, China.
Qi HuangDepartment of Oncology, The First People's Hospital of Neijiang, Neijiang, 641000, Sichuan Province, China.
Yuan LuoDepartment of Rehabilitation, The First People's Hospital of Neijiang, Neijiang, 641000, Sichuan Province, China.
Zhe WuDepartment of Radiology, The First People's Hospital of Neijiang, Neijiang, 641000, Sichuan Province, China.
Jing ChenDepartment of Pediatrics, The First People's Hospital of Neijiang, Neijiang, 641000, Sichuan Province, China. 983394631@qq.com.
Haibo GongDepartment of Rehabilitation, The First People's Hospital of Neijiang, Neijiang, 641000, Sichuan Province, China. 2225968823@qq.com.

Funding

the Neijiang Science and Technology Plan Project 2024NJJCYJZYY008
6 · The paper itself

Abstract

backgroundThe global prevalence of cardiometabolic multimorbidity (CMM) has created a substantial health burden. The triglyceride-total cholesterol-body weight index (TCBI), a novel and easily computed metabolic indicator, has shown a robust association with stroke and cardiovascular disease (CVD). However, research on the risk assessment of CMM remains limited. This study aims to investigate the relationships between cumulative exposure to the TCBI (CumTCBI) and its longitudinal trajectories with the risk of incident CMM in middle-aged and older adults, as well as to develop a survival-based risk prediction model.

methodsData from the China Health and Retirement Longitudinal Study (CHARLS) were utilized. Cox proportional hazards models and restricted cubic spline (RCS) analyses were applied to evaluate the associations between CumTCBI and the risk of CMM. Trajectory patterns of TCBI were discerned through K-means clustering. Subgroup and interaction analyses were conducted. Extensive sensitivity analyses were performed, including lag analysis, complete-case analysis, trimmed RCS analysis, interval-censored survival analysis, and Fine-Gray competing risk models. The proportional hazards assumption was verified using Schoenfeld residuals test. Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI) were calculated to assess incremental predictive value. A survival nomogram prediction model based on Cox regression was developed, with discrimination assessed using the time-dependent area under the receiver operating characteristic curve (ROC) and clinical utility evaluated through decision curve analysis (DCA).

resultsAmong 5068 participants, 424 individuals (8.4%) developed incident CMM during the follow-up period. Following multivariable adjustment, each 1-SD increase in CumTCBI was associated with an 18% higher risk of CMM (HR = 1.18, 95%CI 1.09-1.28), and the highest tertile was linked to an increased risk of CMM compared to the lowest tertile (HR = 1.90, 95% CI 1.43-2.52). A significant nonlinear dose-response relationship between CumTCBI and the riks of CMM (P for nonlinearity < 0.001). Three distinct trajectories are identified (low-stable, moderate-stable, and high-stable), with participants in the high-stable group facing a 61% greater risk of CMM than those with consistently low TCBI (HR = 1.61, 95% CI 1.10-2.36). These associations remained consistent across subgroups and were robust in all sensitivity. The proportional hazards assumption was satisfied (global P = 0.86). NRI and IDI analyses confirmed that TCBI provided incremental predictive value beyond its individual components (NRI = 0.158, P < 0.001). The nomogram prediction model exhibited acceptable discrimination (AUC: 0.715 in the training cohort and 0.694 in the validation cohort), and DCA indicated a favorable clinical net benefit.

conclusionHigher cumulative TCBI exposure and unfavorable TCBI trajectories are independently associated with increased CMM risk in middle-aged and older Chinese adults. The Cox-based nomogram provides a practical tool for early risk stratification, supporting targeted preventino and personalized management of CMM.

Indexed as

Body WeightCardiovascular DiseasesCholesterolTriglyceridesAgedAge FactorsBiomarkersCardiometabolic Risk FactorsChinaEast Asian PeopleFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedBiomarkersCholesterolTriglyceridesCardiometabolic multimorbidity (CMM)CHARLSCumulative exposureNomogramTriglyceride–total cholesterol–body weight index (TCBI)

Identifiers

PMID41906174
PMCPMC13151372

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.